Skip to main content

Table 1 Association between CFP1 and 14-3-3 expression and clinical characteristics of 84 patients with GC

From: The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancer

 

CFP1 expression No.

P

14-3-3 expression No.

P

0

3

6

9

12

0

3

6

9

12

Age

 ≥ 58

2

21

11

4

6

0.196

0

14

21

4

5

0.012

 < 58

4

12

7

9

8

2

14

7

12

5

Sex

 Male

4

23

12

6

8

0.633

1

15

20

9

8

0.46

 Female

2

10

6

7

6

1

13

8

7

2

Tumor invasion (T)

 T1

4

11

2

0

0

0

0

7

7

3

0

0.576

 T2

1

3

3

0

0

0

1

4

0

2

 T3

1

13

7

4

2

1

7

9

6

4

 T4

0

6

6

9

12

1

13

8

7

4

Lymphnode metastasis (N)

 N0

4

21

9

2

1

0.001

0

12

18

6

1

0.343

 N1

1

4

2

3

1

1

4

2

2

2

 N2

1

1

1

2

0

0

2

2

0

1

 N3

0

4

5

2

3

1

5

3

3

2

 Nx

0

3

1

4

9

0

5

3

5

4

Metastasis (M)

 M0

6

30

16

7

5

0

2

22

24

10

6

0.266

 M1

0

3

2

6

9

0

6

4

6

4

Stage

 I

4

13

4

0

0

0

0

7

10

3

1

0.242

 II

2

11

6

2

2

0

7

10

4

2

 III

0

6

6

5

3

2

8

4

3

3

 IV

0

3

2

6

9

0

6

4

6

4

R0 resection

 Yes

6

31

17

10

9

0.031

2

25

25

14

7

0.542

 No

0

2

1

3

5

0

3

3

2

3

Postoperative chemotherapy

 Yes

0

13

10

7

6

0.155

2

9

12

7

6

0.314

 No

2

10

0

2

3

0

5

8

4

0

 Uncertain

4

10

8

4

5

0

14

8

5

4

Level of differentiation

 Well

0

3

0

1

0

0.518

0

3

1

0

0

0.761

 Middle

2

11

4

5

2

1

8

9

4

2

 Poor

4

19

14

7

12

1

17

18

12

8